Premium
EASI p‐EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers
Author(s) -
Bakker Daphne S.,
Ariens Lieneke F. M.,
Giovan Barbara,
Hijnen DirkJan,
Delemarre Eveline M.,
Knol Edward,
Nierkens Stefan,
BruinWeller Marjolein S.,
Thijs Judith L.,
Drylewicz Julia
Publication year - 2020
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/all.14492
Subject(s) - eczema area and severity index , atopic dermatitis , biomarker , medicine , dupilumab , ccl17 , scorad , disease , chemokine receptor , oncology , immunology , dermatology life quality index , chemokine , inflammation , biology , biochemistry